193 related articles for article (PubMed ID: 28879702)
1. Diagnostic Values of sVEGFR-1 and Endostatin in Malignant Pleural Effusions in Patients with Lung Cancer.
Zhu YY; Wu HM; Liu RY
Clin Lab; 2017 Sep; 63(9):1371-1378. PubMed ID: 28879702
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer.
Zhang Y; Yu LK; Lu GJ; Xia N; Xie HY; Hu W; Hao KK; Xu CH; Qian Q
Asian Pac J Cancer Prev; 2014; 15(19):8435-40. PubMed ID: 25339042
[TBL] [Abstract][Full Text] [Related]
5. Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions.
Tomimoto H; Yano S; Muguruma H; Kakiuchi S; Sone S
J Med Invest; 2007 Feb; 54(1-2):146-53. PubMed ID: 17380026
[TBL] [Abstract][Full Text] [Related]
6. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
7. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
8. Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.
Chen Y; Liang B; Zhao YJ; Wang SC; Fan YB; Wu GP
Diagn Cytopathol; 2012 Apr; 40(4):287-91. PubMed ID: 22431315
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion.
Zhang Y; Yu LK; Xia N
Asian Pac J Trop Med; 2012 Mar; 5(3):239-42. PubMed ID: 22305792
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor with tumour growth factor-beta, endostatin, proteinases or cytokines might be useful for differential diagnosis of pleural effusions.
Koniari I; Koletti B; Apostolakis E
Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):424-5. PubMed ID: 21345827
[No Abstract] [Full Text] [Related]
12. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
Xu CH; Zhan P; Yu LK; Zhang XW
Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
[TBL] [Abstract][Full Text] [Related]
13. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
[TBL] [Abstract][Full Text] [Related]
15. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.
Yang J; Zhu Y; Wu L; Zhu W; Zhang X; Yang Y; Xu C
Clin Respir J; 2018 Jan; 12(1):279-284. PubMed ID: 27402224
[TBL] [Abstract][Full Text] [Related]
17. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine: new tumor marker in pleural fluid.
Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
[TBL] [Abstract][Full Text] [Related]
20. The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.
Fiorelli A; Morgillo F; Fasano M; Vicidomini G; Di Crescenzo VG; Di Domenico M; Accardo M; Santini M
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):263-9. PubMed ID: 23190621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]